Ciciriello S, Littlejohn G, Treuer T, Gibson KA, Haladyj E, Youssef P, Bird P, O'Sullivan C, Smith T, Deakin CT; OPAL Rheumatology. Comparative Effectiveness of First-Line Baricitinib in Patients With Rheumatoid Arthritis in the Australian OPAL Data Set. ACR Open Rheumatol. 2023 Jul;5(7):345-353. doi: 10.1002/acr2.11577. Epub 2023 Jun 12. |
Deakin CT, De Stavola BL, Littlejohn G, Griffiths H, Ciciriello S, Youssef P, Mathers D, Bird P, Smith T, O'Sullivan C, Freeman T, Segelov D, Hoffman D, Seaman SR; OPAL Rheumatology Network. Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in Australia. JAMA Netw Open. 2023 Jun 1;6(6):e2320851. doi: 10.1001/jamanetworkopen.2023.20851. |
Deakin CT, Littlejohn GO, Griffiths H, Ciciriello S, O'Sullivan C, Smith T, Youssef P, Bird P; OPAL consortium. Comparative effectiveness of etanercept originator and biosimilar for treating rheumatoid arthritis: implications for cost-savings. Intern Med J. 2024 May;54(5):795-801. doi: 10.1111/imj.16296. Epub 2023 Nov 27. |
Fairley JL, Hansen D, Ross L, Proudman S, Sahhar J, Ngian GS, Walker J, Host LV, Morrisroe K, Apostolopoulous D, Ferdowsi N, Wilson M, Tabesh M, Stevens W, Nikpour M; Australian Scleroderma Interest Group. Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis. Arthritis Res Ther. 2023 May 12;25(1):77. doi: 10.1186/s13075-023-03059-x. |
Ferreira GE, Zadro J, Jones C, Ayre J, Lin C, Richards B, Needs C, Abdel Shaheed C, McLachlan A, Day RO, Maher C. General practitioners' decision-making process to prescribe pain medicines for low back pain: a qualitative study. BMJ Open. 2023 Oct 29;13(10):e074380. doi: 10.1136/bmjopen-2023-074380. |
Jee AS, Stewart I, Youssef P, Adelstein S, Lai D, Hua S, Stevens W, Proudman S, Ngian GS, Glaspole IN, Moodley YP, Bleasel JF, Macansh S, Nikpour M, Sahhar J, Corte TJ; Australian Scleroderma Cohort Study, Australian Scleroderma Interest Group, Australian Idiopathic Pulmonary Fibrosis Registry, and associated investigators. A Composite Serum Biomarker Index for the Diagnosis of Systemic Sclerosis-Associated Interstitial Lung Disease: A Multicenter, Observational Cohort Study. Arthritis Rheumatol. 2023 Aug;75(8):1424-1433. doi: 10.1002/art.42491. Epub 2023 May 15. |
Jones CMP, Day RO, Koes BW, Latimer J, Maher CG, McLachlan AJ, Billot L, Shan S, Lin CC; OPAL Investigators Coordinators. Opioid analgesia for acute low back pain and neck pain (the OPAL trial): a randomised placebo-controlled trial. Lancet. 2023 Jul 22;402(10398):304-312. doi: 10.1016/S0140-6736(23)00404-X. Epub 2023 Jun 28. Erratum in: Lancet. 2023 Aug 19;402(10402):612. |
Li N, Leong R, Youssef P. Combination non tumour necrosis factor biologic and small-molecule therapy in a patient with ankylosing spondylitis and Crohn disease. Intern Med J. 2023 Jun;53(6):1083-1084. doi: 10.1111/imj.16120. |
Melman A, Maher CG, Needs C, Richards B, Rogan E, Teng MJ, Machado GC. Management of patients with low back pain admitted to hospital: An observational study of usual care. Int J Rheum Dis. 2023 Jan;26(1):60-68. doi: 10.1111/1756-185X.14449. Epub 2022 Oct 7. |
Melman A, Vella SP, Dodd RH, Coombs DM, Richards B, Rogan E, Teng MJ, Maher CG, Ghinea N, Machado GC. Clinicians' Perspective on Implementing Virtual Hospital Care for Low Back Pain: Qualitative Study. JMIR Rehabil Assist Technol. 2023 Nov 21;10:e47227. doi: 10.2196/47227. |
Oliveira CB, Coombs D, Machado GC, McCaffery K, Richards B, Pinto RZ, O'Keeffe M, Maher CG, Christofaro DGD. Process evaluation of the implementation of an evidence-based model of care for low back pain in Australian emergency departments. Musculoskelet Sci Pract. 2023 Jun 26;66:102814. doi: 10.1016/j.msksp.2023.102814. Online ahead of print. |
Pisaniello HL, Lester S, Russell O, Black R, Tieu J, Richards B, Barrett C, Lassere M, March L, Buchbinder R, Whittle SL, Hill CL. Trajectories of self-reported pain-related health outcomes and longitudinal effects on medication use in rheumatoid arthritis: a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD). RMD Open. 2023 Jul;9(3):e002962. doi: 10.1136/rmdopen-2022-002962. |
Solomon JJ, Danoff SK, Woodhead FA, Hurwitz S, Maurer R, Glaspole I, Dellaripa PF, Gooptu B, Vassallo R, Cox PG, Flaherty KR, Adamali HI, Gibbons MA, Troy L, Forrest IA, Lasky JA, Spencer LG, Golden J, Scholand MB, Chaudhuri N, Perrella MA, Lynch DA, Chambers DC, Kolb M, Spino C, Raghu G, Goldberg HJ, Rosas IO; TRAIL1 Network Investigators. Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study. Lancet Respir Med. 2023 Jan;11(1):87-96. doi: 10.1016/S2213-2600(22)00260-0. Epub 2022 Sep 5. |
Spiera R, Kuwana M, Khanna D, Hummers L, Frech TM, Stevens W, Matucci-Cerinic M, Kafaja S, Distler O, Jun JB, Levy Y, Leszcyzński P, Gordon J, Steen V, Lee EB, Jankowski T, Litinsky I, Chung L, Hsu V, Mayes M, Sandorfi N, Simms RW, Finzel S, de Vries-Bouwstra J, Constantine S, Dgetluck N, Dinh Q, Bloom BJ, Furst DE, White B, Denton CP; RESOLVE-1 Study Group. Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis. Arthritis Rheumatol. 2023 Sep;75(9):1608-1618. doi: 10.1002/art.42510. Epub 2023 Jun 15. |
Taylor WJ, Willink R, O'Connor DA, Patel V, Bourne A, Harris IA, Whittle SL, Richards B, Clavisi O, Green S, Hinman RS, Maher CG, Cahill A, McPherson A, Hewson C, May SE, Walker B, Robinson PC, Ghersi D, Fitzpatrick J, Winzenberg T, Fallon K, Glasziou P, Billot L, Buchbinder R. Which clinical research questions are the most important? Development and preliminary validation of the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network Research Question Importance Tool (ANZMUSC-RQIT). PLoS One. 2023 Mar 17;18(3):e0281308. doi: 10.1371/journal.pone.0281308. |
Tymms K, O'Sullivan C, Smith T, Littlejohn G, Freeman T, Hoffman D, Segelov D, Griffiths H, Ciciriello S, Youssef P, Mathers D, Deakin CT. A novel electronic patient-reported outcome delivery system to implement health-related quality of life measures in routine clinical care: An analysis of 5 years of experience. Front Digit Health. 2023 Jan 9;4:1074931. doi: 10.3389/fdgth.2022.1074931. |
Youssef M, Youssef P. Methotrexate osteopathy. Intern Med J. 2023 Nov;53(11):2141-2142. doi: 10.1111/imj.16265. |